SCHEMBL10077103

SCHEMBL10077103

COc1cccc(/C(C=O)=C(/C=O)N2CCN(C(=O)C(=O)c3c[nH]c4c(OC)ncc(OC)c34)CC2)c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.65
CYP3A4 P08684 2/20 0.49
CYP2D6 P10635 2/20 0.48
CYP1A2 P05177 1/20 0.48
CYP2C8 P10632 1/20 0.48
CYP2B6 P20813 1/20 0.48
CYP2C19 P33261 1/20 0.48
KCNH2 Q12809 1/20 0.48
BTK Q06187 2/20 0.36
ALDH1A1 P00352 3/20 0.36
HPGD P15428 1/20 0.36
ABL1 P00519 6/20 0.35
BCR P11274 6/20 0.35
CNR1 P21554 1/20 0.34
CNR2 P34972 1/20 0.34
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA7 P43166 1/20 0.34
CA9 Q16790 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10077421 0.82 CYP2C9 (0.62) CYP2C9CYP3A4CYP2D6CYP1A2CYP2C8
SCHEMBL12752449 0.82 CYP2C9 (0.69) CYP2C9CYP3A4CYP2D6CYP1A2CYP2C8
SCHEMBL30966670 0.79 CYP2C9 (1.00) CYP2C9CYP3A4CYP2D6CYP1A2CYP2C8
SCHEMBL2688411 0.79 CYP2C9 (1.00) CYP2C9CYP3A4CYP2D6CYP1A2CYP2C8
SCHEMBL13899202 0.77 CYP2C9 (0.60) CYP2C9CYP3A4CYP2D6CYP1A2CYP2C8
SCHEMBL12152014 0.77 CYP2C9 (0.81) CYP2C9CYP3A4CYP2D6CYP1A2CYP2C8
SCHEMBL12151715 0.76 CYP2C9 (0.75) CYP2C9CYP3A4CYP2D6CYP1A2CYP2C8
SCHEMBL12752456 0.76 CYP2C9 (0.72) CYP2C9CYP3A4CYP2D6CYP1A2CYP2C8
SCHEMBL12752444 0.75 CYP2C9 (0.78) CYP2C9CYP3A4CYP2D6CYP1A2CYP2C8
SCHEMBL12751544 0.75 CYP2C9 (0.77) CYP2C9CYP3A4CYP2D6CYP1A2CYP2C8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2013170-B1 4-SQUARYLPIPERAZINE DERIVATIVES AS ANTIVIRAL AGENTS BRISTOL MYERS SQUIBB CO (US) 2012-06-27 EP disclosed